시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 골반 염증성 질환(PID) 치료 시장 보고서(2025년)
Pelvic Inflammatory Disease (PID) Treatment Global Market Report 2025
상품코드 : 1720860
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,226,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,000,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,773,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

골반 염증성 질환(PID) 치료 시장 규모는 향후 몇 년 동안 높은 성장세를 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 성병(STI) 유병률 증가, 여성 생식 건강에 대한 인식 증가, 골반 염증성 질환(PID)에 대한 인식 증가, 원격 의료 서비스에 대한 의존도 증가, 성병 발생률 증가에 기인한 것으로 볼 수 있습니다. 이 기간 동안 예상되는 주요 트렌드에는 혁신적인 PID 치료 제품, 진단 기술의 발전, 개인 맞춤형 치료의 혁신, 첨단 이미징 기술 및 기타 기술 발전이 포함됩니다.

성병(STI)의 유병률 증가는 골반 염증성 질환(PID) 치료 시장의 성장을 견인할 것으로 예상됩니다. 성병은 주로 질, 항문 또는 구강 성교를 포함한 성적 접촉을 통해 전파되는 박테리아, 바이러스 또는 기생충에 의한 감염입니다. 성병 유병률의 증가는 위험한 성행위, 무방비 성관계, 인식 부족, 검사 및 치료 지연과 같은 요인에 기인합니다. 항생제를 사용하여 감염을 일으키는 박테리아를 제거하고 만성 골반통 및 불임과 같은 합병증을 예방하며 재발 위험을 줄이기 위해 항생제를 사용하는 PID 치료는 성매개감염병 관리에 매우 중요합니다. 예를 들어, 2024년 10월 영국 보건안보국(UKHSA)의 보고서에 따르면 2023년 영국에서 6,008건의 새로운 HIV 진단이 발생하여 2022년의 3,975건에 비해 51% 증가했다고 합니다. 따라서 성병 유병률의 증가는 PID 치료 시장의 확장을 주도하고 있습니다.

골반 염증성 질환(PID) 치료 시장에 진출한 기업들은 치료 효능을 높이고 질 내 미생물 균형을 회복하며 PID 환자의 감염 재발을 줄이기 위해 프로바이오틱스 보충제와 같은 혁신적인 제형 개발에 집중하고 있습니다. 프로바이오틱 보충제는 장과 질 내 미생물의 건강한 균형을 유지하거나 회복하는 데 도움이 되는 유익한 살아있는 박테리아 또는 효모를 함유하고 있습니다. 예를 들어, 2024년 11월 인도에 본사를 둔 제약 회사인 Lee Health Domain은 질 건강 지원을 목적으로 하는 프로바이오틱 보충제인 V-Ferin을 출시했습니다. 락토바실러스 아시도필루스, 락토페린 펩타이드, 크랜베리 추출물로 제조된 V-Ferin은 천연 미생물 군집을 복원하고 세균성 질염 및 효모 감염과 같은 일반적인 질 감염을 예방하는 것을 목표로 합니다. 여성의 약 25-30%가 이러한 질환의 영향을 받고 있으며, 치료하지 않고 방치할 경우 PID로 이어질 수 있기 때문에 V-Ferin은 건강을 개선하고 합병증을 예방할 수 있는 혁신적인 솔루션을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Pelvic inflammatory disease (PID) treatment involves the medical management of infections affecting the female reproductive organs, typically caused by sexually transmitted bacteria such as Chlamydia trachomatis and Neisseria gonorrhoeae. The goal of treatment is to eliminate the infection, alleviate symptoms, and prevent complications such as infertility, chronic pelvic pain, and ectopic pregnancy.

The main types of PID treatment include antibiotic therapy, surgery, pain management, and hormonal therapy. Antibiotic therapy involves using antibiotics to treat bacterial infections by killing or inhibiting the growth of bacteria. It can be administered orally, intravenously, or intramuscularly, and PID treatment is available in hospitals, clinics, and home care settings.

The pelvic inflammatory disease (PID) treatment market research report is one of a series of new reports from The Business Research Company that provides pelvic inflammatory disease (PID) treatment market statistics, including the pelvic inflammatory disease (PID) treatment industry global market size, regional shares, competitors with the pelvic inflammatory disease (PID) treatment market share, detailed pelvic inflammatory disease (PID) treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the pelvic inflammatory disease (PID) treatment industry. This pelvic inflammatory disease (PID) treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pelvic inflammatory disease (PID) treatment market size has grown strongly in recent years. It will grow from $4.49 billion in 2024 to $4.75 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to the growing adoption of telemedicine, the rising incidence of sexually transmitted infections (STIs), increasing awareness of pelvic inflammatory disease (PID), and higher healthcare expenditure.

The pelvic inflammatory disease (PID) treatment market size is expected to see strong growth in the next few years. It will grow to $5.88 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth during the forecast period can be attributed to the increasing prevalence of sexually transmitted infections (STIs), rising awareness regarding women's reproductive health, growing awareness of pelvic inflammatory disease (PID), increasing reliance on telehealth services, and a rising incidence of STIs. Key trends expected during this period include innovative PID treatment products, advancements in diagnostic technologies, innovations in personalized treatment, advanced imaging techniques, and other technological advancements.

The rising prevalence of sexually transmitted infections (STIs) is expected to drive the growth of the pelvic inflammatory disease (PID) treatment market. STIs are infections caused by bacteria, viruses, or parasites that are primarily spread through sexual contact, including vaginal, anal, or oral sex. The increasing prevalence of STIs is attributed to factors such as risky sexual behaviors, unprotected sex, lack of awareness, and delayed testing and treatment. PID treatment is crucial for managing STIs, as it involves the use of antibiotics to eliminate the bacteria causing the infection, preventing complications such as chronic pelvic pain and infertility, and reducing the risk of recurrent infections. For example, in October 2024, a report from the UK Health Security Agency (UKHSA) revealed that in 2023, England recorded 6,008 new HIV diagnoses, marking a 51% increase compared to 3,975 in 2022. Therefore, the growing prevalence of STIs is driving the expansion of the PID treatment market.

Companies operating in the pelvic inflammatory disease (PID) treatment market are focusing on developing innovative formulations, such as probiotic supplements, to enhance treatment efficacy, restore vaginal microbiota balance, and reduce the recurrence of infections in PID patients. Probiotic supplements contain beneficial live bacteria or yeasts that help maintain or restore a healthy balance of the gut and vaginal microbiota. For example, in November 2024, Lee Health Domain, an India-based pharmaceutical company, launched V-Ferin, a probiotic supplement aimed at supporting vaginal health. Formulated with Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract, V-Ferin seeks to restore the natural microbiome and prevent common vaginal infections such as bacterial vaginosis and yeast infections. With approximately 25-30% of women affected by these conditions, which can lead to PID if left untreated, V-Ferin offers an innovative solution to improve health and prevent complications.

In February 2022, Mankind Pharma Limited, an India-based pharmaceutical company, acquired Panacea Biotec Limited (PBL) for $212.88 million. This acquisition strengthens Mankind Pharma's position in the chronic and transplant business by integrating well-researched formulations and leveraging advanced technology and niche expertise, while retaining Panacea Biotec's sales and marketing team to ensure seamless business operations and market expansion. Panacea Biotec Limited is an India-based biotechnology company that develops, manufactures, and commercializes pharmaceuticals, vaccines, and biosimilars for various diseases, including pelvic inflammatory disease (PID).

Major players in the pelvic inflammatory disease (PID) treatment market are Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., and Amagen India Life Sciences.

North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pelvic inflammatory disease (PID) treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pelvic inflammatory disease (PID) treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pelvic inflammatory disease (PID) treatment market consists of revenues earned by entities by providing services such as medication therapy, pain management, and hospital and clinic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pelvic inflammatory disease (PID) treatment market includes sales of antibiotics, pain relievers, and supportive care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values generated by organizations in the specified geography within the market, irrespective of where they are produced. They do not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pelvic Inflammatory Disease (PID) Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pelvic inflammatory disease (pid) treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for pelvic inflammatory disease (pid) treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pelvic inflammatory disease (pid) treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Pelvic Inflammatory Disease (PID) Treatment Market Characteristics

3. Pelvic Inflammatory Disease (PID) Treatment Market Trends And Strategies

4. Pelvic Inflammatory Disease (PID) Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pelvic Inflammatory Disease (PID) Treatment Growth Analysis And Strategic Analysis Framework

6. Pelvic Inflammatory Disease (PID) Treatment Market Segmentation

7. Pelvic Inflammatory Disease (PID) Treatment Market Regional And Country Analysis

8. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market

9. China Pelvic Inflammatory Disease (PID) Treatment Market

10. India Pelvic Inflammatory Disease (PID) Treatment Market

11. Japan Pelvic Inflammatory Disease (PID) Treatment Market

12. Australia Pelvic Inflammatory Disease (PID) Treatment Market

13. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market

14. South Korea Pelvic Inflammatory Disease (PID) Treatment Market

15. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market

16. UK Pelvic Inflammatory Disease (PID) Treatment Market

17. Germany Pelvic Inflammatory Disease (PID) Treatment Market

18. France Pelvic Inflammatory Disease (PID) Treatment Market

19. Italy Pelvic Inflammatory Disease (PID) Treatment Market

20. Spain Pelvic Inflammatory Disease (PID) Treatment Market

21. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market

22. Russia Pelvic Inflammatory Disease (PID) Treatment Market

23. North America Pelvic Inflammatory Disease (PID) Treatment Market

24. USA Pelvic Inflammatory Disease (PID) Treatment Market

25. Canada Pelvic Inflammatory Disease (PID) Treatment Market

26. South America Pelvic Inflammatory Disease (PID) Treatment Market

27. Brazil Pelvic Inflammatory Disease (PID) Treatment Market

28. Middle East Pelvic Inflammatory Disease (PID) Treatment Market

29. Africa Pelvic Inflammatory Disease (PID) Treatment Market

30. Pelvic Inflammatory Disease (PID) Treatment Market Competitive Landscape And Company Profiles

31. Pelvic Inflammatory Disease (PID) Treatment Market Other Major And Innovative Companies

32. Global Pelvic Inflammatory Disease (PID) Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pelvic Inflammatory Disease (PID) Treatment Market

34. Recent Developments In The Pelvic Inflammatory Disease (PID) Treatment Market

35. Pelvic Inflammatory Disease (PID) Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기